...
首页> 外文期刊>Rheumatology international. >Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism
【24h】

Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism

机译:纤维母细胞性风湿病患者对甲氨蝶呤治疗的良好临床反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fibroblastic rheumatism (FR) is a rare disease first described by Chaouat (in Rev Rhum Mal Osteoartic 47:345-351, 1980) and is characterized by a combination of rheumatologic and dermatological manifestations. Rheumatologic features are symmetrical polyarthralgias with joint stiffness, associated with cutaneous nodules and sclerodactyly. Histology shows an increased number of fibroblasts and a marked dermal fibrosis. A large number of treatments have been tried, but all of them have shown an unpredictable effect on FR. We report a Brazilian case of FR showing a good clinical response to methotrexate treatment. This drug may be considered an effective treatment in FR.
机译:纤维化风湿病(FR)是一种罕见的疾病,最初由Chaouat(在Rh Rhum Mal Osteoartic 47:345-351中发表,1980)进行描述,其特征是风湿病和皮肤病学表现的结合。风湿病学特征是对称性多关节痛,关节僵硬,伴有皮肤结节和硬化。组织学显示成纤维细胞数量增加和明显的皮肤纤维化。已经尝试了许多治疗方法,但是所有方法均显示出对FR的不可预测的作用。我们报告了巴西一例FR,对甲氨蝶呤治疗表现出良好的临床反应。该药物可被认为是FR的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号